Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency - Concepedia

Concepedia

Publication | Open Access

Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency

DOI Full Paper Access

24

Citations

34

References

2022

Year

Peter Bergman, David Wullimann, Yu Gao, Emilie Wahren Borgström, Anna-Carin Norlin, Sara Lind Enoksson, Soo Aleman, Hans‐Gustaf Ljunggren, Marcus Buggert

Journal of Clinical Immunology

References

	Year	Citations

Page 1